Advanced imaging application for acute ischemic stroke

Emergency Radiology

Volumn 11, Issue 2, 2004, Pages 77-82

  Farkas, Jeffrey ^a,b   Xavier, Andrew ^c   Prestigiacomo, Charles J ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b Department of Radiology   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; PROUROKINASE;

BLEEDING; BRAIN ANGIOGRAPHY; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CLINICAL TRIAL; COLLATERAL CIRCULATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; FIBRINOLYTIC THERAPY; HUMAN; IMAGING SYSTEM; INSTITUTIONAL CARE; MORBIDITY; MULTICENTER STUDY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; STRATIFICATION; STROKE; ANIMAL; BRAIN ISCHEMIA; METHODOLOGY; PATHOPHYSIOLOGY;

ANIMALS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; HUMANS; MAGNETIC RESONANCE IMAGING; THROMBOLYTIC THERAPY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 17844389108     PISSN: 10703004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10140-004-0347-2     Document Type: Review

References (29)

1. 2001 Heart and Stroke Statistical Update (2002) American Stroke Association, Dallas, pp 1-8
2. del Zoppo GJ, et al (1992) Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 32:78-86
3. Jones TH, et al (1981) Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg 54:773-782
4. Zivin JA, et al (1985) Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science 230:1289-1292
5. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995 333:1581-1587
6. Albers GW, et al (2002) ATLANTIS trial: results for patients treated within 3 hours of stroke onset. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. Stroke 33:493-495
7. Albers GW, et al (2000) Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 283:1145-1150
8. Clark WM, et al (1999) Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 282:2019-2026
9. Hacke W, et al (1998) Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 352:1245-1251
10. del Zoppo GJ, et al (1998) PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 29:4-11
11. Furlan A, et al (1999) Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282:2003-2011
12. Katzan IL, et al (2000) Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 283:1151-1158
13. Chiu D, et al (1998) Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke 29:18-22
14. Morgenstern LB, et al (2002) Improving delivery of acute stroke therapy: The TLL Temple Foundation Stroke Project. Stroke 33:160-166
15. Christou I, et al (2000) Timing of recanalization after tissue plasminogen activator therapy determined by transcranial Doppler correlates with clinical recovery from ischemic stroke. Stroke 31:1812-1816
16. von Kummer R, et al (1997) Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology 205:327-333
17. Bryan RN, et al (1991) Diagnosis of acute cerebral infarction: comparison of CT and MR imaging. AJNR Am J Neuroradiol 12:611-620
18. Truwit CL, et al (1990) Loss of the insular ribbon: another early CT sign of acute middle cerebral artery infarction. Radiology 176:801-806
19. Tomura N, et al (1988) Early CT finding in cerebral infarction: obscuration of the lentiform nucleus. Radiology 168:463-467
20. Xavier AR, et al. (2003) Neuroimaging of stroke: a review. South Med J 96:367-379
21. Lev MH, et al (1999) Acute stroke: improved nonenhanced CT detection - benefits of soft-copy interpretation by using variable window width and center level settings. Radiology 213:150-155
22. Barber PA, et al (2001) Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 56:1015-1020
23. Hamberg LM, et al (1996) Quantitative high-resolution measurement of cerebrovascular physiology with slip-ring CT. AJNR Am J Neuroradiol 17:639-650
24. Hunter GJ, et al (1998) Assessment of cerebral perfusion and arterial anatomy in hyperacute stroke with three-dimensional functional CT: early clinical results. AJNR Am J Neuroradiol 19:29-37
25. Ringleb PA, et al (2002) Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful? Stroke 33:1437-1441
26. Kent DM, R Ruthazer and HP Selker (2003) Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset? Stroke 34:464-467
27. Lev MH, et al (2001) CT angiography in the rapid triage of patients with hyperacute stroke to intraarterial thrombolysis: accuracy in the detection of large vessel thrombus. J Comput Assist Tomogr 25:520-528
28. Christou I, et al (2002) Intravenous tissue plasminogen activator and flow improvement in acute ischemic stroke patients with internal carotid artery occlusion. J Neuroimaging 12:119-123
29. Libman RB, et al (1995) Conditions that mimic stroke in the emergency department. Implications for acute stroke trials. Arch Neurol 52:1119-1122